Testing a Vaginal Gel for HPV-Related Cervical Health
Part of Cancer, Infections, Women’s health & pregnancy clinical trials.
This study is testing a vaginal gel that might help restore the health of the cervix in women who have HPV. If you have HPV and your cervical cells are normal or only mildly abnormal, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman aged 30 to 50.
- You must have a recent HPV-positive test result (within the last 3 months).
- Your cervical cells must show no abnormalities or only mild changes (ASC-US, LSIL, or AGC).
- You must not have had cervical surgery (like a cone biopsy or hysterectomy) in the past year or ever.
- You must not be pregnant, planning pregnancy, or breastfeeding, and if you can become pregnant, you must use reliable birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a self-collected sample for HPV testing works as well as standard colposcopy to prevent cervical cancer. If you've recently had an abnormal cervical cancer screening and need a colposcopy, this trial may be an option for you.
This study tests whether a vaginal gel can help early cervical cell changes (CIN1 or CIN2) go away on their own and clear the HPV virus. If you are being monitored without treatment, this gel might increase your chances of recovery.
This study tests a new vaginal medication (Dysplasix) to treat mild cervical cell changes caused by high-risk HPV. The goal is to see if this treatment can help your body clear the virus and prevent these changes from getting worse.
This Phase 1 study tests FluBHPVE6E7, a new treatment designed to help the immune system respond to HPV16. It mainly checks safety and the best dose, and may help your body clear or control HPV over time.
This trial studies 2LPAPI® to see if it helps the body clear high-risk HPV infections in the cervix. It may be an option if you have a current HPV infection with mild/early abnormal cervical findings and can complete follow-up for about a year.
This trial tests whether an HPV vaccine (the nonavalent type) can help prevent the same precancerous lesions from coming back after treatment. It is for people who currently have a high-grade HPV-related lesion but have not yet been treated for it.
Hear when a new Human Papillomavirus Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.